麻醉前胃超声与GLP-1受体激动剂治疗麻醉考虑的韩国共识建议
本共识由韩国麻醉医师学会临床实践指南委员会制定,针对麻醉前胃超声评估及接受GLP-1受体激动剂治疗患者的麻醉管理。因当前证据不足,采用专家讨论与文献复习的共识方式形成建议。内容涵盖胃超声适应证、检查原则与解读、围术期决策整合、无法行超声时的处理及饱胃患者的麻醉策略。
要点
- 麻醉前胃超声可床旁定性定量评估胃内容物与容积,辅助个体化误吸风险分层
- GLP-1受体激动剂治疗患者多数建议继续用药,疑似胃排空延迟时考虑术前24小时清流质饮食
- 超声提示饱胃时应调整麻醉策略,但建议不能替代临床判断
核心结论
- 麻醉前胃超声是一种实用的床旁方法,可用于评估接受麻醉患者的胃内容物并估计误吸风险
- 当前证据不足以支持正式的有证据分级临床实践指南,本建议基于专家共识而非有力证据
- GLP-1受体激动剂治疗患者多数应继续用药并行个体化风险评估,疑似胃排空延迟时建议术前24小时清流质饮食
研究设计与样本
- 制定机构为韩国麻醉医师学会临床实践指南委员会
- 方法为专家讨论与现有文献复习相结合形成共识性建议
- 研究类型为共识声明,并非基于正式证据分级的临床实践指南
关键影像表现/征象
- 麻醉前胃超声可对胃内容物进行定性与定量评估,包括胃内容物性质和容积
- 超声可识别饱胃状态,为误吸风险分层提供影像学依据
诊断标准与关键数值
- 胃超声核心检查原则与解读方法在共识中予以说明,但未提供具体敏感度、特异度或AUC数值
- GLP-1受体激动剂治疗患者的特殊建议包括多数患者继续用药、个体化风险评估、疑似胃排空延迟时考虑24小时清流质饮食及使用胃超声
临床应用与阅片要点
- 建议涵盖胃超声的适应证、检查原则与解读、超声发现整合入围术期决策
- 无法实施胃超声时应采取相应麻醉管理策略
- 超声提示饱胃患者需调整麻醉方案
- GLP-1受体激动剂治疗患者疑似胃排空延迟时建议行胃超声评估
局限性
- 当前证据基础不足以支持正式的有证据分级临床实践指南,缺乏有力证据
- 建议基于专家讨论与文献复习形成,需通过未来前瞻性结局研究进一步验证与完善
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pulmonary aspiration during anesthesia remains an uncommon but clinically significant perioperative complication associated with substantial morbidity and mortality. Although contemporary fasting guidelines recommend minimum fasting intervals to reduce aspiration risk, adherence does not guarantee an empty stomach, particularly in patients with delayed gastric emptying or those receiving medications that impair gastrointestinal motility, such as glucagon-like peptide-1 receptor agonist (GLP-1 RA)-based therapies. Preanesthetic gastric ultrasound has emerged as a practical point-of-care modality for the qualitative and quantitative assessment of gastric content and volume, enabling individualized aspiration risk stratification in selected patients. However, the current evidence base remains insufficient to formally support evidence-graded clinical practice guidelines. The consensus-based recommendations presented in this guideline were developed through expert discussion and review of the available literature, in which robust evidence is lacking. They provide practical guidance on the indications for preanesthetic gastric ultrasound, core examination principles and interpretation, integration of ultrasound findings into perioperative decision-making, management when gastric ultrasound is not feasible, and anesthetic strategies for patients with a full stomach. Special recommendations are included for patients receiving GLP-1 RA-based therapies, emphasizing the continuation of these medications in most patients with individualized risk assessment, consideration of a 24-h clear liquid diet, and the use of gastric ultrasound when delayed gastric emptying is suspected. Preanesthetic gastric ultrasound provides a practical bedside method for assessing gastric content and estimating aspiration risk in patients undergoing anesthesia. These recommendations are intended to support, not replace, clinical judgment and should be refined through future prospective outcome-based studies.
引用
- Bang, Choi, Min, et al. Korean consensus-based recommendations for preanesthetic gastric ultrasound and anesthetic considerations for GLP-1 receptor agonist-based therapy: a consensus statement from Clinical Practice Guideline Committee of the Korean Society of Anesthesiologists. Korean J Anesthesiol. 2026. PMID: 42529794. doi:10.4097/kja.26655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。